AUTHORITY: Implementing and authorized by Section 100 of the Illinois Controlled Substances Act [720 ILCS 570/100].

SOURCE: Filed and effective November 19, 1975; rules repealed, new rules adopted at 2 Ill. Reg. 16, p. 151, effective April 24, 1978; amended at 2 Ill. Reg. 33, p. 63, effective August 15, 1978; amended at 2 Ill. Reg. 44, p. 127, effective October 30, 1978; amended at 2 Ill. Reg. 45, p. 19, effective November 10, 1978; amended at 2 Ill. Reg. 52, p. 283, effective January 5, 1979; amended at 3 Ill. Reg. 8, p. 112, effective February 23, 1979; amended at 3 Ill. Reg. 12, p. 246, effective March 23, 1979; amended at 4 Ill. Reg. 33, p. 193, effective August 4, 1980; amended at 5 Ill. Reg. 2987, effective March 5, 1981; amended at 5 Ill. Reg. 5156, effective April 29, 1981; amended at 5 Ill. Reg. 13454, effective November 25, 1981; amended at 6 Ill. Reg. 5176, effective April 16, 1982; amended at 6 Ill. Reg. 7200, effective June 7, 1982; amended at 7 Ill. Reg. 16142, effective December 2, 1983; amended at 7 Ill. Reg. 16639, effective December 9, 1983; transferred to the Department of Alcoholism and Substance Abuse by the Alcoholism and Substance Abuse Act (supp. to Ill. Rev. Stat. 1983, ch. 111 1/2, pars. 634 et seq.) effective July 1, 1984; amended at 8 Ill. Reg. 13138, effective July 27, 1984; amended at 8 Ill. Reg. 16760, effective September 14, 1984; codified at 8 Ill. Reg. 19319; amended at 8 Ill. Reg. 21212, effective October 19, 1984; amended at 9 Ill. Reg. 1837, effective January 29, 1985; amended at 9 Ill. Reg. 10649, effective July 2, 1985; amended at 10 Ill. Reg. 914, effective January 7, 1986; amended at 10 Ill. Reg. 11222, effective June 16, 1986; emergency amendment at 10 Ill. Reg. 15662, effective September 10, 1986, for a maximum of 150 days; amended at 10 Ill. Reg. 18159, effective October 8, 1986; amended at 10 Ill. Reg. 19709, effective November 6, 1986; emergency amendment at 11 Ill. Reg. 4048, effective February 24, 1987, for a maximum of 150 days; amended at 11 Ill. Reg. 5192, effective March 17, 1987; amended at 11 Ill. Reg. 11944, effective July 2, 1987; amended at 20 Ill. Reg. 3081, effective February 2, 1996; recodified from Department of Alcoholism and Substance Abuse to Department of Human Services at 21 Ill. Reg. 9319; peremptory amendment at 38 Ill. Reg. 8439, effective April 7, 2014; peremptory amendment at 39 Ill. Reg. 3171, effective February 13, 2015; peremptory amendment at 39 Ill. Reg. 16482, effective December 17, 2015; emergency amendment at 40 Ill. Reg. 13718, effective September 13, 2016, for a maximum of 150 days; amended at 41 Ill. Reg. 1801, effective January 25, 2017; peremptory amendment at 41 Ill. Reg. 7014, effective June 1, 2017; amended at 45 Ill. Reg. 13018, effective October 4, 2021.

SUBPART A: GENERAL

 

Section 2070.10  Definitions

 

a)         "Act" as used in this part means the "Illinois Controlled Substances Act," effective August 16, 1971, as amended.

 

b)         The definitions contained in Section 102 of the Act are applicable herein, unless the context otherwise requires.

 

Section 2070.20  Designated Products

 

The Department finds that the following Controlled Substances listed in Schedule II (Subpart C) require use of an official prescription blank for dispensation:  any narcotic drug, amphetamine, glutethimide, phenmetrazine, methamphetamine, pentazocine, or cannabis product.

 

(Source:  Amended at 11 Ill. Reg. 5192, effective March 17, 1987)

 

Section 2070.30  Names Given to Listed Drugs

 

The controlled substances listed or to be listed in the schedules contained in this part are included by whatever official, common, usual, chemical or trade name designated.

 

Section 2070.40  Excluded Substances

 

The non-narcotic substances excluded from all schedules of the Federal Controlled Substances Act (21 U.S.C. 801 et seq.) as of January 1, 1974, pursuant to Section 1308.22 of the Code of Federal Regulations (21 CFR 1308.22), are excluded from all schedules of the Act.

 

Section 2070.50  Excepted Compounds

 

The compounds in the form excepted from application of certain specified sections of the Federal Controlled Substances Act (21 U.S.C. 801 et seq.), the Federal Controlled Substances Import and Export Act (21 U.S.C. 951 et seq.), and the Code of Federal Regulations, pursuant to Section 1308.32 of the Code of Federal Regulations(21 C.F.R. 1308.32) are excepted from the application of Sections 312 and 313 of this Act.

SUBPART B: SCHEDULE OF CONTROLLED SUBSTANCES - SCHEDULE I

 

Section 2070.100  Schedule I − Criteria

 

The Department finds that the substances enumerated in Schedule I following meet the criteria established in Section 203 of the Act.

 

Section 2070.110  Schedule I − Enumeration

 

The controlled substances listed in these Sections 2070.110 to 2070.810 are included in Schedule I.

 

Section 2070.115  Opiates

 

Unless specifically excepted or unless listed in another schedule, any of the following opiates listed in Sections 2070.120 to 2070.395, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

 

Section 2070.117  AB-CHMINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

 

AB-CHMINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole‑3‑carboxamide

 

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 3171, effective February 13, 2015)

 

Section 2070.118  AB-PINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

 

AB-PINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1Hindazole-3-carboxamide

 

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 3171, effective February 13, 2015)

 

Section 2070.120  Acetylmethadol

 

Acetylmethadol

 

Section 2070.122  Acetyl-alpha-methylfentanyl

 

Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-

phenylacetamide

 

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.124  Alfentanil (Renumbered)

 

(Source:  Former Section 2070.124 renumbered to Section 2070.1186 at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.125  Allylprodine

 

Allylprodine

 

Section 2070.130  Alphacetylmethadol

 

Alphacetylmethadol, except levo-alphacetylmethadol (also known as:  levo-alpha-

acetylmethadol, levomethadyl acetate, or LAAM)

 

(Source:  Amended at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.135  Alphameprodine

 

Alphameprodine

 

Section 2070.140  Alphamethadol

 

Alphamethadol

 

Section 2070.145  Alpha-methylfentanyl

 

Alpha-methylfentanyl (N-(l-alpha-methyl-beta-phenyl)ethyl-4-piperidyl)

propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)

piperidine)

 

(Source:  Amended at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.146  Alpha-methylthiofentanyl

 

Alpha-methylthiofentanyl (N-[1-menthyl-2-(2-thienyl) ethyl-4-piperideinyl]-N-

phenylpropanamide)

 

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.147  1-methyl-4-phenyl-4-propionoxypiperdine (MPPP)

 

1-methyl-4-phenyl-4-propionoxypiperdine (MPPP)

 

(Source:  Added at 10 Ill. Reg. 11222, effective June 16, 1986)

 

Section 2070.148  PEPAP 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine

 

PEPAP 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine)

 

(Source:  Amended at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.150  Benzethidine

 

Benzethidine

 

Section 2070.155  Betacetylmethadol

 

Betacetylmethadol

 

Section 2070.157  Beta-hydroxyfentanyl

 

Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-

phenylpropanamide)

 

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.160  Betameprodine

 

Betameprodine

 

Section 2070.165  Betamethadol

 

Betamethadol

 

Section 2070.170  Betaprodine

 

Betaprodine

 

Section 2070.175  Clonitazene

 

Clonitazene

 

Section 2070.180  Dextromoramide

 

Dextromoramide

 

Section 2070.185  Diampromide

 

Diampromide

 

Section 2070.190  Diethylthiambutene

 

Diethylthiambutene

 

Section 2070.195  Difenoxin

 

Difenoxin

 

Section 2070.200  Dimenoxadol

 

Dimenoxadol

 

Section 2070.205  Dimepheptanol

 

Dimepheptanol

 

Section 2070.210  Dimethylthiambutene

 

Dimethylthiambutene

 

Section 2070.220  Dioxaphetylbutyrate

 

Dioxaphetylbutyrate

 

Section 2070.230  Dipipanone

 

Dipipanone

 

Section 2070.235  Ethylmethylthiambutene

 

Ethylmethylthiambutene

 

Section 2070.240  Etonitazene

 

Etonitazene

 

Section 2070.245  Etoxeridine

 

Etoxeridine

 

Section 2070.247  3-Methylfentanyl (Renumbered)

 

(Source:  Former Section 2070.247 renumbered to Section 2070.272 at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.250  Furethidine

 

Furethidine

 

Section 2070.255  Hydroxpethidine

 

Hydroxpethidine

 

Section 2070.260  Ketobemidone

 

Ketobemidone

 

Section 2070.265  Levomoramide

 

Levomoramide

 

Section 2070.270  Levophenacylmorphan

 

Levophenacylmorphan

 

Section 2070.271  U-47700

 

U-47700 3,4-dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methylbenzamide

 

(Source:  Added at 41 Ill. Reg. 1801, effective January 25, 2017)

 

Section 2070.272  3-Methylfentanyl

 

3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)

 

(Source:  Section 2070.272 renumbered from Section 2070.247 and amended at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.273  3-Methylthiofentanyl

 

3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenyl-

propanamide)

 

(Source:  Added at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.275  Morpheridine

 

Morpheridine

 

Section 2070.280  Noracymethadol

 

Noracymethadol

 

Section 2070.285  Norlevorphanol

 

Norlevorphanol

 

Section 2070.290  Normethadone

 

Normethadone

 

Section 2070.295  Norpipanone

 

Norpipanone

 

Section 2070.297  Para-fluorofentanyl

 

Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide)

 

(Source:  Added at 20 Ill. Reg 3081 effective February 2, 1996)

 

Section 2070.300  Phenadoxone

 

Phenadoxone

 

Section 2070.310  Phenampromide

 

Phenampromide

 

Section 2070.320  Phenomorphan

 

Phenomorphan

 

Section 2070.330  Phenoperidine

 

Phenoperidine

 

Section 2070.340  Piritramide

 

Piritramide

 

Section 2070.350  Proheptazine

 

Proheptazine

 

Section 2070.360  Properidine

 

Properidine

 

Section 2070.370  Propiram

 

Propiram

 

Section 2070.380  Racemoramide

 

Racemoramide

 

Section 2070.385  Sufentanil (Renumbered)

 

(Source:  Section 2070.385 renumbered to Section 2070.1265 at 8 Ill. Reg. 21212, effective October 19, 1984)

 

Section 2070.388  Thiofentanyl

 

Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.389  THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl) methanone

 

THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone

 

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 3171, effective February 13, 2015)

 

Section 2070.390  Tilidine

 

Tilidine

 

(Source:  Amended at 5 Ill. Reg. 5156, effective April 29, 1984)

 

Section 2070.395  Trimeperidine

 

Trimeperidine

 

Section 2070.397  Beta-hydroxy-3-methylfentanyl

 

Beta-hydroxy-3-methylfentanyl (other name:  N-[1-(2-hydroxy-2-phenethyl)-3-

methyl-4-piperidinyl]-N-phenylpropanamide)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.400  Opium Derivates

 

Unless specifically excepted or unless listed in another schedule, any of the opium derivatives, listed in the following Sections 2070.405 to 2070.520, its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation listed.

 

Section 2070.405  Acetorphine

 

Acetorphine

 

Section 2070.410  Acetyldihydrocodeine

 

Acetyldihydrocodeine

 

Section 2070.412  Alpha-pyrrolidinobutiophenone ("a-PBP")

 

Alpha-pyrrolidinobutiophenone ("a-PBP")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.414  Alpha-pyrrolidinopentiophenone ("a-PVP")

 

Alpha-pyrrolidinopentiophenone ("a-PVP")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.415  Benzylmorphine

 

Benzylmorphine

 

Section 2070.420  Codeine methylbromide

 

Codeine methylbromide

 

Section 2070.425  Codeine-N-Oxide

 

Codeine-N-Oxide

 

Section 2070.430  Cyprenorphine

 

Cyprenorphine

 

Section 2070.435  Desomorphine

 

Desomorphine

 

Section 2070.440  Diacetyldihydromorphine (Dihydroheroin)

 

Diacetyldihydromorphine (Dihydroheroin)

 

Section 2070.445  Dihydromorphine

 

Dihydromorphine

 

Section 2070.450  Drotebanol

 

Drotebanol

 

Section 2070.455  Etorphine (except hydrochloride salt)

 

Etorphine (except hydrochloride salt)

 

Section 2070.460  Heroin

 

Heroin

 

Section 2070.465  Hydromorphinol

 

Hydromorphinol

 

Section 2070.470  Methyldesorphine

 

Methyldesorphine

 

Section 2070.475  Methyldihydromorphine

 

Methyldihydromorphine

 

Section 2070.480  Morphine methylbromide

 

Morphine methylbromide

 

Section 2070.485  Morphine methylsulfonate

 

Morphine methylsulfonate

 

Section 2070.490  Morphine-N-Oxide

 

Morphine-N-Oxide

 

Section 2070.495  Myrophine

 

Myrophine

 

Section 2070.500  Nicocodeine

 

Nicocodeine

 

Section 2070.505  Nicomorphine

 

Nicomorphine

 

Section 2070.510  Normorphine

 

Normorphine

 

Section 2070.515  Pholcodine

 

Pholcodine

 

Section 2070.520  Thebacon

 

Thebacon.

 

Section 2070.530  1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one ("butylone")

 

1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one ("butylone")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.540  1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one ("pentylone")

 

1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (“pentylone”)

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.545 1-(naphthalene-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one ("naphyrone")

 

1-(naphthalene-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one ("naphyrone")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.600  Hallucinogenic Substances

 

Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the hallucinogenic substances listed in the following Sections 2070.605 to 2070.715, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.  (For the purpose of Sections 2070.600 to 2070.715 only, the term "isomer" includes the optical, position and geometric isomers listed in the following Sections 2070.605 to 2070.715).

 

Section 2070.602  2-(methylamino)-1-phenylpentan-1-one ("pentedrone")

 

2-(methylamino)-1-phenylpentan-1-one ("pentedrone")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.604  3-fluoro-N-methylcathinone ("3-FMC")

 

3-fluoro-N-methylcathinone ("3-FMC")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.605  3, 4 Methylenedioxyamphetamine

 

3, 4-methylenedioxyamphetamine (alphamethyl, 3, 4-methylenedioxy-phenethylamine, methylenedioxyamphetamine, MDA)

 

Section 2070.606  Alpha-ethyltryptamine

 

Alpha-ethyltryptamine (some trade or other names:  etryptamine; MOASE, alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl)indole; a-ET, and AET)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.607  3,4 Methylenedioxymethamphetamine (MDMA)

 

3,4 Methylenedioxymethamphetamine

 

(Source:  Added at 10 Ill. Reg. 18159, effective October 8, 1986)

 

Section 2070.608  3,4-methylenedioxy-N-ethylamphetamine

 

3,4-methylenedioxy-N-ethylamphetamine (also known as:  N-ethyl-alpha-methyl-

3,4(methylenedioxy) Phenethylamine, N-ethyl, MDA, MDE, and MDEA)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.610  3-methoxy-4, 5-methylenedioxyamphetamine, MMDA

 

3-methoxy-4, 5-methylenedioxyamphetamine, MMDA

 

Section 2070.615  3, 4, 5-trimethoxyamphetamine (TMA)

 

3, 4, 5-trimethoxyamphetamine (TMA)

 

Section 2070.616  4-fluoro-N-methylcathinone ("4-FMC")

 

4-fluoro-N-methylcathinone ("4-FMC")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.617  4-methyl-N-ethylcathinone ("4-MEC")

 

4-methyl-N-ethylcathinone ("4-MEC")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.618  4-methylapha-pyrrolidinopropiophenone ("4-MePPP")

 

4-methylapha-pyrrolidinopropiophenone ("4-MePPP")

 

(Source:  Added by peremptory rulemaking at 38 Ill. Reg. 8439, effective April 7, 2014)

 

Section 2070.619  N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl)

 

N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters and ethers.

 

(Source:  Added by peremptory rulemaking at 41 Ill. Reg. 7014, effective June 1, 2017)

 

Section 2070.620  5-hydroxydimethyltryptamine (Bufotenine)

 

5-hydroxydimethyltryptamine (Bufotenine)

 

Section 2070.625  Diethyltryptamine (DET)

 

Diethyltryptamine (DET)

 

Section 2070.630  Dimethyltryptamine (DMT)

 

Dimethyltryptamine (DMT)

 

Section 2070.635  4-methyl, 2, 5-dimethoxyamphetamine (DOM, STP)

 

4-methyl, 2, 5-dimethoxyamphetamine (DOM, STP)

 

Section 2070.640  Ibogaine

 

Ibogaine (some trade and other names:  7-ethyl-6,6,beta,7,8,9,10,12,12-octahydro-

2-methoxy-6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole; Tabernatnthe

iboga)

 

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.645  Lysergic acid diethylamide

 

Lysergic acid diethylamide

 

Section 2070.650  3, 4, 5-trimethoxyphenethylamine (Mescaline)

 

3, 4, 5-trimethoxyphenethylamine (Mescaline)

 

Section 2070.655  Peyote

 

Peyote (meaning all parts of the plant presently classified botanically as Lophophora williemaii Lemaire, whether growing or not, the seeds thereof, any extract from any part of that plant, and every compound, manufacture, salts, derivative, mixture, or preparation of that plant, its seeds or extracts)

 

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.660  N-ethyl-3-piperidyl benzilate (JB 318)

 

N-ethyl-3-piperidyl benzilate (JB 318)

 

Section 2070.665  N-methyl-3-piperidyl benzilate

 

N-methyl-3-piperidyl benzilate

 

Section 2070.667  N-hydroxy-3,4-methylenedioxyamphetamine

 

N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-

3,4(methylenedioxy)phenethylamine and N-hydroxy MDA)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.670  Parahexyl

 

Parahexyl; some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6 H-dibenzo (b,d) pyran; synhexyl.

 

Section 2070.675  Psilocybin

 

Psilocybin

 

Section 2070.680  Psilocyn

 

Psilocyn

 

Section 2070.685  Alpha-methyltryptamine (AMT)

 

Alpha-methyltryptamine (AMT)

 

Section 2070.690  2,5-dimethoxyamphetamine

 

2,5-dimethoxyamphetamine (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA)

 

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.695  4-bromo-2,5-dimethoxyamphetamine

 

4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA)

 

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.700  4-methoxyamphetamine (4-methoxy-alpha-methylphenethylamine;

paramethoxyamphetamine, PMA)

 

4-methoxyamphetamine (4-methoxy-alpha-methylphenethylamine;

paramethoxyamphetamine, PMA)

 

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.705  Thiophene analog of phencyclidine (TPCP)

 

Thiophene analog of phencyclidine (TPCP)

 

Section 2070.710  Ethylamine analog of phencyclidine

 

Ethylamine analog of phencyclidine.  Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE

 

(Source:  Added at 3 Ill. Reg. 8, p. 112, effective February 23, 1979)

 

Section 2070.715  Pyrrolidine analog of phencyclidine

 

Pyrrolidine analog of phencyclidine.  Some trade or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy, PHP.

 

(Source:  Added at 3 Ill. Reg. 8, p. 112, effective February 23, 1979)

 

Section 2070.720  5-methoxy-3,4-methylenedioxy-amphetamine

 

5-methoxy-3,4-methylenedioxy-amphetamine

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.725  2,5-dimethoxy-4-ethylamphetamine

 

2,5-dimethoxy-4-ethylamphetamine (another name:  DOET)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.730  1-[1-(2-thienyl)cyclohexy1] pyrrolidine

 

1-[1-(2-thienyl)cyclohexyl] pyrrolidine (another name:  TCPy)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.735  3,4-methylenedioxy-amphetamine

 

3,4-methylenedioxy amphetamine

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.740  Thiophene analog of phencyclidine

 

Thiophene analog of phencyclidine (some trade or other names:  1-[1-(2-

thienyl)-cyclohexyl]-piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.745  Bufotenine

 

Bufotenine (some trade or other names:  3-(Beta-Dimethylaminoethyl)

-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; 5-hydroxy-N,N-

dimethyltryptamine; N,N-dimethylserotonin; mappine

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.750  Depressants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.755 to 2070.760 having a depressant effect on the central nervous system including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

 

Section 2070.755  Mecloqualone

 

Mecloqualone

 

Section 2070.760  Methaqualone

 

Methaqualone

 

(Source:  Renumbered from Section 2070.1405 at 8 Ill. Reg. 16760, effective September 14, 1984)

 

Section 2070.800  Stimulants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.805 and 2070.810 having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.

 

Section 2070.805  Fenethylline

 

Fenethylline

 

Section 2070.810  N-ethylamphetamine

 

N-ethylamphetamine

 

Section 2070.815  Aminorex

 

Aminorex (some other names:  2-amino-5-phenyl-2-oxazoline; aminoxaphen; 4-5-dihydro-5-phenyl-2-oxazolamine) and its salts, optical isomers, and salts of optical isomers

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.820  Methcathinone

 

Methcathinone (some other names:  2-methylamino-1-phenylpropan-1-one;

Ephedrone; 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; N-methylcathinone; methycathinone; Monomethylpropion; UR 1431) and its salts, optical isomers, and salts of optical isomers.

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.825  Chathinone

 

Chathinone (some trade or other names:  2-aminopropiophenone; alpha-

aminopropiophenone; 2-amino-1-phenyl-propane; norephedrone)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.830  N,N-dimethylamphetamine

 

N,N-dimethylamphetamine (also known as:  N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.835  (+ or -) cis-4-methylaminorex

 

(+ or -) cis-4-methylaminorex ((+ or -) cis-4,5-dihydro-4-methyl-4-5-

phenyl-2-oxazolamine)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.619  N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl)

 

N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl), and its isomers, esters, ethers, salts and salts of isomers, esters and ethers.

 

(Source:  Added by peremptory rulemaking at 41 Ill. Reg. 7014, effective June 1, 2017)

SUBPART C: SCHEDULE OF CONTROLLED SUBSTANCES--SCHEDULE II

 

Section 2070.900  Schedule II − Criteria

 

The Department finds that the substances enumerated in Schedule II following meet the criteria established in Section 205 of the Act.

 

Section 2070.910  Schedule II − Enumeration

 

The controlled substances listed in these Sections 2070.915 to 2070.1510 are included in Schedule II.

 

Section 2070.915  Narcotics

 

Unless specifically excepted or unless listed in another schedule, any of the substances listed in Sections 2070.920 to 2070.1130 whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis.

 

Section 2070.920  Opium and Opiates

 

Opium and opiates, and any salt, compound, derivative or preparation of opium or opiate, excluding apomorphine, dextrorphan, levopropoxyphene, nalbuphine, naloxone, and naltrexone, and their respective salts, but including those enumerated in Sections 2070.925 to 2070.998.

 

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.925  Raw Opium

 

Raw opium

 

Section 2070.930  Opium Extracts

 

Opium extracts

 

Section 2070.935  Opium Fluid Extracts

 

Opium fluid extracts

 

Section 2070.940  Powdered Opium

 

Powdered opium

 

Section 2070.945  Granulated Opium

 

Granulated opium

 

Section 2070.950  Tincture of Opium

 

Tincture of opium

 

Section 2070.955  Codeine

 

Codeine

 

Section 2070.960  Ethylmorphine

 

Ethylmorphine

 

Section 2070.965  Etorphine Hydrochloride

 

Etorphine Hydrochloride

 

Section 2070.970  Hydrocodone

 

Hydrocodone

 

Section 2070.975  Hydromorphone

 

Hydromorphone

 

Section 2070.980  Metopon

 

Metopon

 

Section 2070.985  Morphine

 

Morphine

 

Section 2070.990  Oxycodone

 

Oxycodone

 

Section 2070.995  Oxymorphone

 

Oxymorphone

 

Section 2070.998  Thebaine

 

Thebaine

 

Section 2070.999  Thebaine-derived butorphanol

 

Thebaine-derived butorphanol

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1100  Equivalencies

 

Any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in Section 2070.920, but not including the isoquinoline alkaloids of opium.

 

Section 2070.1110  Opium poppy and poppy straw

 

Opium poppy and poppy straw

 

Section 2070.1120  Cocaine

 

Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves, which extractions do not contain cocaine or ecgonine (for the purpose of this paragraph, the term "isomer" includes optical, positional and geometric isomers).

 

(Source:  Amended at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1130  Concentrate of Poppy Straw

 

Concentrate of poppy straw (the crude extract of poppy  straw in either liquid, solid or powder form which contains the phenanthrine alkaloids of the opium poppy).

 

Section 2070.1150  Opiates

 

Unless specifically excepted or unless listed in another schedule any of the opiates listed in Sections 2070.1155 to 2070.1265, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation, dextrorphan excepted.

 

(Source:  Amended at 8 Ill. Reg. 21212, effective October 19, 1984)

 

Section 2070.1155  Alphaprodine

 

Alphaprodine

 

Section 2070.1160  Anileridine

 

Anileridine

 

Section 2070.1165  Bezitramide

 

Bezitramide

 

Section 2070.1170  Bulk Dextropropoxyphene

 

Bulk Dextropropoxyphene (Non-dosage forms)

 

Section 2070.1175  Dihydrocodeine

 

Dihydrocodeine

 

Section 2070.1180  Diphenoxylate

 

Diphenoxylate

 

Section 2070.1185  Fentanyl

 

Fentanyl

 

Section 2070.1186  Alfentanil

 

Alfentanil

 

(Source:  Renumbered from Section 2070.124 at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1187  Carfentanil

 

Carfentanil

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1190  Isomethadone

 

Isomethadone

 

Section 2070.1193  Levo-alphacetylmethadol

 

Levo-alphacetylmethadol (some other names:  levo-alpha-acetylmethadol, levomethadyl acetate, LAAM)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1195  Levomethorphan

 

Levomethorphan

 

Section 2070.1200  Levorphanol

 

Levorphanol (Levorphan)

 

Section 2070.1205  Metazocine

 

Metazocine

 

Section 2070.1210  Methadone

 

Methadone

 

Section 2070.1215  Methadone--Intermediate

 

Methadone--Intermediate, 4-cyano-2 dimethylamino-4,4-diphenyl-1-butane

 

Section 2070.1220  Moramide--Intermediate

 

Moramide--Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane--carboxylic acid

 

Section 2070.1225  Meperidine

 

Pethidine (meperidine)

 

Section 2070.1230  Pethidine-Intermediate-A

 

Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

 

Section 2070.1235  Pethidine-Intermediate-B

 

Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

 

Section 2070.1240  Pethidine-Intermediate-C

 

Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

 

Section 2070.1245  Phenazocine

 

Phenazocine

 

Section 2070.1250  Piminodine

 

Piminodine

 

Section 2070.1255  Racemethorphan

 

Racemethorphan

 

Section 2070.1260  Racemorphan

 

Racemorphan

 

Section 2070.1265  Sufentanil

 

Sufentanil

 

(Source:  Section 2070.1265 renumbered from Section 2070.385 at 8 Ill. Reg. 21212, effective October 19, 1984)

 

Section 2070.1300  Stimulants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1310 to 2070.1370 having a stimulant effect on the central nervous system.

 

Section 2070.1310  Amphetamine

 

Amphetamine, its salts, optical isomers and salts of its optical isomers.

 

Section 2070.1320  Methamphetamine

 

Methamphetamine, its salts, isomers, and salts of its isomers.

 

Section 2070.1330  Methylphenidate

 

Methylphenidate

 

(Source:  Renumbered from Section 2070.1750 at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1370  Phenmetrazine

 

Phenmetrazine and its salts.

 

Section 2070.1400  Depressants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1405 to 2070.1435 having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

 

Section 2070.1405  Methaqualone (Renumbered)

 

(Source:  Renumbered to Section 2070.760 at 8 Ill. Reg. 16760, effective September 14, 1984)

 

Section 2070.1410  Amobarbital

 

Amobarbital

 

Section 2070.1420  Secobarbital

 

Secobarbital

 

Section 2070.1425  Pentobarbital

 

Pentobarbital

 

Section 2070.1430  Phencyclidine

 

Phencyclidine

 

Section 2070.1435  Pentazocine

 

Pentazocine

 

Section 2070.1438  Gluthethimide

 

Gluthethimide

 

(Source:  Renumbered from 2070.1835 at 8 Ill. Reg. 13138, effective July 27, 1984)

 

Section 2070.1500  Immediate Precursors

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1505 to 2070.1510.

 

Section 2070.1505  Amphetamine and Methamphetamine

 

Immediate precursor to amphetamine and methamphetamine:

            Phenylacetone.  Some trade or other names:  phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.

 

Section 2070.1510  Phencyclidine

 

Immediate precursors to phencyclidine.

 

a)         1-phenylcyclohexylamine

 

b)         1-piperidinocyclohexanecarbonitrile (PCC).

 

Section 2070.1520  Nabilone

 

Nabilone

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1550  Dronabinol (oral solution)

 

Dronabinol (oral solution) and other names:  (6aR, 10aR)-6a,7,8,10a-tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-o1.

 

(Source:  Amended at 45 Ill. Reg. 13018, effective October 4, 2021)

SUBPART D: SCHEDULE OF CONTROLLED SUBSTANCES--SCHEDULE III

 

Section 2070.1600  Schedule III − Criteria

 

The Department finds that the substances enumerated in Schedule III following meet the criteria established in Section 207 of the Act.

 

Section 2070.1605  Schedule III − Enumeration

 

The controlled substances listed in these Sections 2070.1615 to 2070.2000 are included in Schedule III.

 

Section 2070.1610  Stimulants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1615 to 2070.1640 having s stimulant effect on the central nervous system, including its salts, isomers, (whether optical position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

 

Section 2070.1615  Excepted Compounds

 

Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under  21 CFR 308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances.

 

Section 2070.1620  Benzphetamine

 

Benzphetamine

 

Section 2070.1625  Chlorphentermine

 

Chlorphentermine

 

Section 2070.1630  Clortermine

 

Clortermine

 

Section 2070.1635  Mazindol (Renumbered)

 

Mazindol

 

(Source:  Renumbered to Section 2070.2540 at 6 Ill. Reg. 7200, effective June 7, 1982)

 

Section 2070.1640  Phendimetrazine

 

Phendimetrazine

 

Section 2070.1700   Other Stimulants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the substances listed in Section 2070.1750 having a potential for abuse associated with a stimulant effect on the central nervous system:

 

Section 2070.1750  Methylphenidate (Renumbered)

 

(Source:  Former Section 2070.1750 renumbered to Section 2070.1330 at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1800  Depressants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1805 to 2070.1875 having a potential for abuse associated with a depressant effect on the central nervous system.

 

Section 2070.1805  Barbiturates

 

Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or any salt of any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

 

Section 2070.1810  Barbiturates − Suppository Dosage Form

 

Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or any salt of any of these drugs and approved by the Federal Food and Drug Administration for marketing only as a suppository.

 

Section 2070.1825  Derivatives of Barbituric Acid

 

Any substance which contains any quantity of a derivative of barbituric acid, or any salt thereof.

 

Section 2070.1830  Chlorhexadol

 

Chlorhexadol

 

Section 2070.1835  Glutethimide

 

Glutethimide

 

(Source:  Renumbered to 2070.1438 at 8 Ill. Reg. 13135, effective July 27, 1984)

 

Section 2070.1840  Methyprylon

 

Methyprylon

 

Section 2070.1845  Sulfondiethylmethane

 

Sulfondiethylmethane

 

Section 2070.1850  Sulfonethylmethane

 

Sulfonethylmethane

 

Section 2070.1855  Sulfonmethane

 

Sulfonmethane

 

Section 2070.1860  Lysergic Acid

 

Lysergic acid

 

Section 2070.1865  Lysergic Acid Amide

 

Lysergic acid amide

 

Section 2070.1868  Tiletamine or Zolazepam or Both

 

Tiletamine or zolazepam or both, or any salt of either of them.  Some trade or other names for a tiletamine-zolazepam combination product:  Telazol.  Some trade or other names for tiletamine:  2-(ethylamino)-2-(2-thienyl)- cyclohexanone.  Some trade or other names for zolazepam:  4-(2-fluorophenyl)- 6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1870  Pentazocine and Aspirin Compound

 

Any material, compound, mixture or preparation containing not more than 12.5 milligrams of pentazocine or any of its salts, per 325 milligrams of aspirin.

 

Section 2070.1875  Pentazocine and Acetaminophine

 

Any material, compound, mixture or preparation containing not more than 25 milligrams of Pentazocine or any of its salts, per 650 milligrams of Acetaminophen.

 

Section 2070.1880  Pentazocine and Naloxone

 

Pentazocine and Naloxone

Any material, compound, mixture or preparation containing not more than 50 milligrams of pentazocine or any of its salts plus naloxone HCl USP 0.5 milligrams, per dosage unit.

 

(Source:  Added at 10 Ill. Reg. 19709, effective November 6, 1986)

 

Section 2070.1890  Nalorphine

 

Nalorphine

 

Section 2070.1900  Narcotic Drugs

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the narcotic drugs listed in Sections 2070.1905 to 2070.1940, or their salts calculated as the free anhydrous base or alkaloid.

 

Section 2070.1905  Codeine

 

Not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.

 

Section 2070.1910  Codeine

 

Not more than 1.8 grams of codeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts.

 

Section 2070.1915  Dihydrocodeinone

 

Not more than 300 milligrams of dihydrocodeinone, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.

 

Section 2070.1920  Dihydrocodeinone

 

Not more than 300 milligrams of dihydrocodeinone, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

 

Section 2070.1925  Dihydrocodeine

 

Not more than 1.8 grams of dihydrocodeine, or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

 

Section 2070.1930  Ethylmorphine

 

Not more than 300 milligrams of ethylmorphine or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

 

Section 2070.1935  Opium

 

Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

 

Section 2070.1940  Morphine

 

Not more than 50 milligrams of morphine, or any of its salts, per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts.

 

Section 2070.1960  Anabolic Steroids

 

Anabolic steroids, except the following anabolic steroids listed in Sections 2070.1962 to 2070.1992 that are exempt.

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1962  Androgen L.A.

 

Androgen L.A.

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1964  Andro-Estro 90-4

 

Andro-Estro 90-4

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1966  depANDROGYN

 

depANDROGYN

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1968  DEPO-T.E.

 

DEPO-T.E.

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1970  depTESTROGEN

 

depTESTROGEN

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1972  Duomone

 

Duomone

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1974  DURATESTRIN

 

DURATESTRIN

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1976  DUO-SPAN II

 

DUO-SPAN II

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1978  Estratest

 

Estratest

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1980  Estratest H.S.

 

Estratest H.S.

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1982  PAN ESTRA TEST

 

PAN ESTRA TEST

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1984  Premarin with Methyltestosterone

 

Premarin with Methyltestosterone

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1986  TEST-ESTRO Cypionates

 

TEST-ESTRO Cypionates

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1988  Testosterone Cyp-50-Estradiol Cyp 2

 

Testrosterone Cyp-50-Estradiol Cyp 2

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1990  Testosterone Cypionate-Estradiol Cypionate Injection

 

Testosterone Cypionate-Estradiol Cypionate injection

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1992  Testosterone Enanthate-Estradiol Valerate Injection

 

Testosterone Enanthate-Estradiol Valerate injection

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.1995 Dronabinol (capsules)

 

Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelation capsule in a U.S. Food and Drug Administration-approved drug product.  Some other names:  (6aR-trans)-6a,7,8,10a_tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-o1; (-)-delta-9(trans)- tetrahydrocannabinol.

 

(Source:  Added at 45 Ill. Reg. 13018, effective October 4, 2021)

 

Section 2070.2000  Excepted Compounds

 

The Department may except by rule any compound, mixture, or preparation containing any stimulant or depressant substance listed in Sections 2070.1610 and 2070.1700 from the application of all or any part of this Act if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

SUBPART E: SCHEDULE OF CONTROLLED SUBSTANCES-- SCHEDULE IV

 

Section 2070.2100  Schedule IV − Criteria

 

The Department finds that the substances enumerated in Schedule IV following meet the criteria established in Section 209 of the Act.

 

Section 2070.2105  Schedule IV − Enumeration

 

The controlled substances listed in these Sections 2070.2110 through 2070.2600 are included in Schedule IV.

 

Section 2070.2110  Narcotic Drugs

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs listed in Sections 2070.2115 and 2070.2120, or their salts calculated as the free anhydrous base or alkaloid.

 

Section 2070.2115  Difenoxin and Atropine Sulfate

 

Not more than 1 milligram of difenoxin (DEA Drug Code No. 9618) and not less than 25 micrograms of atropine sulfate per dosage unit.

 

Section 2070.2120  Dextropropoxyphine

 

Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane).

 

Section 2070.2200  Depressants

 

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.2210 to 2070.2325 having a potential for abuse associated with a depressant effect on the central nervous system.

 

Section 2070.2210  Alprazolam

 

Alprazolam

 

Section 2070.2215  Barbital

 

Barbital

 

Section 2070.2217  Bromazepam

 

Bromazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2218  Camazepam

 

Camazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2220  Chloral Betaine

 

Chloral betaine

 

Section 2070.2225  Chloral Hydrate

 

Chloral hydrate

 

Section 2070.2230  Chlordiazepoxide

 

Chlordiazepoxide

 

Section 2070.2232  Clobazam

 

Clobazam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2235  Clonazepam

 

Clonazepam

 

Section 2070.2240  Clorazepate

 

Clorazepate

 

Section 2070.2241  Clotiazepam

 

Clotiazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2242  Cloxazolam

 

Cloxazolam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2244  Delorazepam

 

Delorazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2245  Diazepam

 

Diazepam

 

Section 2070.2246  Eluxadoline

 

Eluxadoline 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1 H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid

 

(Source:  Added by peremptory rulemaking at 39 Ill. Reg. 16482, effective December 17, 2015)

 

 

Section 2070.2248  Estazolam

 

Estazolam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2250  Ethchlorvynol

 

Ethchlorvynol

 

Section 2070.2255  Ethinamate

 

Ethinamate

 

Section 2070.2256  Ethyl Loflazepate

 

Ethyl loflazepate

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2258  Fludiazepam

 

Fludiazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2259  Flunitrazepam

 

Flunitrazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2260  Flurazepam

 

Flurazepam

 

Section 2070.2265  Halazepam

 

Halazepam

 

Section 2070.2266  Haloxazolam

 

Haloxazolam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2268  Ketazolam

 

Ketazolam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2269  Loprazolam

 

Loprazolam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2270  Lorazepam

 

Lorazepam

 

Section 2070.2272  Lormetazepam

 

Lormetazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2275  Mebutamate

 

Mebutamate

 

Section 2070.2277  Medazepam

 

Medazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2280  Meprobamate

 

Meprobamate

 

Section 2070.2285  Methohexital

 

Methohexital

 

Section 2070.2290  Mephobarbital

 

Methylphenobarbital (Mephobarbital)

 

Section 2070.2291  Midazolam

 

Midazolam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2292  Nimetazepam

 

Nimetazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2293  Nitrazepam

 

Nitrazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2294  Nordiazepam

 

Nordiazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2295  Oxazepam

 

Oxazepam

 

Section 2070.2297  Oxazolam

 

Oxazolam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2300  Paraldehyde

 

Paraldehyde

 

Section 2070.2305  Petrichloral

 

Petrichloral

 

Section 2070.2310  Phenobarbital

 

Phenobarbital

 

Section 2070.2312  Pinazepam

 

Pinazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2315  Prazepam

 

Prazepam

 

Section 2070.2317  Quazepam

 

Quazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2320  Temazepan

 

Temazepan

 

Section 2070.2322  Tetrazepam

 

Tetrazepam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2325  Triazolam

 

Triazolam

 

(Source:  Added at 8 Ill. Reg. 16760, effective September 14, 1984)

 

Section 2070.2350  Zolpidam

 

Zolpidam

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2400  Fenfluramine

 

Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible: Fenfluramine

 

Section 2070.2500  Stimulants

 

Unless specifically excepted or unless listed in another schedule any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1605 to 2070.2580 having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

 

Section 2070.2503  Cathine

 

Cathine ((+)-norpseudoephedrine)

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2505  Diethylpropion

 

Diethylpropion

 

Section 2070.2515  Fencamfamin

 

Fencamfamin

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2520  Fenproporex

 

Fenproporex

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2540  Mazindol

 

Mazindol

 

(Source:  Renumbered from Section 2070.1635 at 6 Ill. Reg. 7200, effective June 7, 1982)

 

Section 2070.2545  Mefenorex

 

Mefenorex

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2565  Phentermine

 

Phentermine

 

Section 2070.2570  Pemoline

 

Pemoline (including organometallic complexes and chelates thereof).

 

Section 2070.2575  Pipradrol

 

Pipradrol

 

Section 2070.2580  SPA

 

SPA ((-)-1-dimethylamino-1, 2-diphenylethane).

 

Section 2070.2600  Excepted Compounds

 

The Department may except by rule any compound, mixture, or preparation containing any depressant substance listed in Section 2070.2110 from the application of all or any part of this Act if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.

 

Section 2070.2650  Stimulants

 

Any material, compound, mixture, or preparation that contains any quantity of the following substance listed in Section 2070.2655 having a stimulant effect on the central nervous system, including its salts, enantiomers (optical isomers) and salts of enantiomers (optical isomers).

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2655  Ephedrine

 

Ephedrine as the only active medicinal ingredient or in combination with therapeutically insignificant quantities of another active medicinal ingredient.  Anything less than 200 milligrams of Guaifenesin shall be considered therapeutically insignificant.

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

SUBPART F: SCHEDULE OF CONTROLLED SUBSTANCES-- SCHEDULE V

 

Section 2070.2700  Schedule V − Criteria

 

The Department finds that the substances enumerated in Schedule V following meet the criteria established in Section 211 of the Act.

 

Section 2070.2705  Schedule V − Enumeration

 

The controlled substances listed in these Sections 2070.2710 to 2070.2800 are included in Schedule V.

 

Section 2070.2710  Narcotic Drugs

 

Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs listed in Sections 2070.2715 to 2070.2740, or their salts calculated as the free anhydrous base or alkaloid, which also contains one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone.

 

Section 2070.2712  Buprenorphine

 

Buprenorphine

 

(Source:  Added at 9 Ill. Reg. 10649, effective July 2, 1985)

 

Section 2070.2715  Codeine

 

Not more than 200 milligrams of codeine, or any of its salts, per 100 milliliters or per 100 grams.

 

Section 2070.2720  Dihydrocodeine

 

Not more than 100 milligrams of dihydrocodeine; or any of its salts, per 100 milliliters or per 100 grams.

 

Section 2070.2723  -Methylfentanyl

 

3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)

 

(Source:  Section 2070.272 renumbered from Section 2070.247 and amended at 20 Ill. Reg 3081, effective February 2, 1996)

 

Section 2070.2725  Ethylmorphine

 

Not more than 100 milligrams of ethylmorphine; or any of its salts, per 100 milliliters or per 100 grams.

 

Section 2070.2730  Diphenoxylate

 

Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.

 

Section 2070.2735  Opium

 

Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.

 

Section 2070.2740  Difenoxin

 

Not more than 0.5 milligram of difenoxin (DEA Drug Code No. 9618) and not less than 25 micrograms of atropine sulfate per dosage unit.

 

Section 2070.2750  Pyrovalerone

 

Pyrovalerone

 

(Source:  Added at 20 Ill. Reg. 3081, effective February 2, 1996)

 

Section 2070.2800  Other Substances

 

Any compound, mixture, or preparation which contains any quantity of any controlled substance when such compound, mixture, or preparation is not otherwise controlled in Schedules I, II, III, or IV.